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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA)-specific hospital discharge
codes were introduced in October 2008. The purpose of this project is to study the correlation of
these codes with laboratory-proven pediatric MRSA bloodstream infections.
Methods: Laboratory and discharge databases were used to identify patients <20 years old
hospitalized at Cincinnati Children’s Hospital Medical Center from October 2008 through
December 2010 with MRSA bloodstream infections. The laboratory database identified patients
with a positive blood culture for MRSA, and the discharge database identified patients with an
MRSA bloodstream discharge code (038.12 for MRSA sepsis or 041.12 for MRSA infection
with either 790.7 for bacteremia or 771.81 for newborn sepsis or 771.83 for newborn
bacteremia). The sensitivity and positive predictive value (PPV) of the codes were determined,
using laboratory-confirmed infection as the gold standard.
Results: During the 27 month study period, 65 patients with MRSA bloodstream infection were
identified from laboratory data and 58 patients were identified from administrative data; 36 were
concordant. The overall sensitivity was 55.4%, and the overall PPV was 62.1%, and neither
showed a significant trend over time. The sensitivity varied with the clinical manifestation of the
bloodstream infection. Of the 22 patients coded for MRSA bloodstream infection without a
positive blood culture, almost half (45.4%) had only a localized MRSA infection. Of the 29
patients with positive MRSA blood culture but insufficient discharge coding, the majority
(55.2%) were coded only for MRSA infection without bloodstream involvement.
Conclusions: Discharge coding for MRSA bloodstream infection was found to be insensitive and
to have a low PPV. Using these codes alone will lead to an underestimation of pediatric MRSA
bloodstream infections.
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Correlation of Discharge Diagnostic Codes with Laboratory-Confirmed MethicillinResistant Staphylococcus aureus Bloodstream Infections at a Large Pediatric Hospital
Infection with methicillin-resistant Staphylococcus aureus (MRSA) has become an
increasingly common pediatric condition over the past 10-15 years. Unfortunately, the overall
current epidemiology of MRSA invasive disease among pediatric patients has not been wellstudied to date, except for small studies in various geographic locations. As has been done with
other conditions, the national epidemiology of invasive pediatric MRSA infections potentially
could be monitored using readily available, large-scale administrative databases containing
International Classification of Diseases 9th Revision (ICD-9) hospital discharge codes. Such
administrative databases can be attractive for use because of their relative ease of availability and
because of the large volume of data that is included. For example, the National Hospital
Ambulatory Medical Care Survey (NHAMCS), the National Hospital Discharge Survey
(NHDS), the Kids’ Inpatient Database (KID), and the Pediatric Health Information System
(PHIS) are large datasets that include ICD-9 codes and have been used to monitor the burden of
various other medical conditions. However, the extent to which these data reflect the true
underlying clinical condition could vary significantly. Therefore, if administrative data will
continue to be used more frequently, specifically for further research regarding pediatric MRSA
infection, then a better understanding of the correlation between discharge diagnosis codes and
clinical MRSA disease must be elucidated.
For this culminating experience project, the hypothesis is that ICD-9 hospital discharge
codes will only moderately correlate with laboratory-proven MRSA bloodstream infections for
children hospitalized at Cincinnati Children’s Hospital Medical Center (CCHMC). Per US
Department of Health and Human Services Centers for Medicare and Medicaid Services,
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hospital discharge codes specific to MRSA only came into effect in October 2008. Prior to this
time, MRSA infections required at least 2 separate codes to adequately document the infection.
Some adult studies done at that time already showed a relatively low sensitivity and positive
predictive value for code combinations in capturing MRSA hospitalizations. Therefore, for this
culminating experience, the project will only focus on hospitalizations after October 2008. The
discharge code information will be obtained from the CCHMC Finance and Health Information
Management Department (discharge database), and the MRSA blood culture information will be
obtained from the CCHMC Infection Control Program (lab database). These two databases will
be compared in order to determine the sensitivity and positive predictive value of the ICD-9
codes for pediatric MRSA bloodstream infections.
This project was approved by the Institutional Review Board at CCHMC, as part of a
larger project assessing the overall burden of Staphylococcus aureus disease.
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Statement of Purpose
The purpose of this project is to better understand the applicability of administrative
hospital discharge data for monitoring the epidemiology of pediatric MRSA bloodstream
infections. The research hypothesis is that ICD-9 hospital discharge codes specific to MRSA
bloodstream infection (038.12 for MRSA sepsis or 041.12 for MRSA infection with either 790.7
for bacteremia or 771.81 for newborn sepsis or 771.83 for newborn bacteremia) will only
moderately correlate with laboratory-confirmed MRSA bloodstream infections among patients
less than 20 years old hospitalized at CCHMC during Oct. 2008 – Dec. 2010. The extent of this
correlation will be based upon measurement of the sensitivity and positive predictive value of the
codes. Further, any discordance between the administrative data and laboratory data will be
assessed through chart review in order to identify reasons for incomplete correlation. This
information is important in order to estimate the burden of and monitor trends for pediatric
MRSA bloodstream infections in the future.
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Review of Literature
Staphylococcus aureus (S. aureus) is a bacterium that commonly colonizes the nasal
mucosa and skin of humans, but it can cause serious invasive disease when it breaches these
outermost defenses. When S. aureus bypasses the skin or mucosal barriers and gains access to
the deeper tissues and bloodstream, it can cause a wide spectrum of disease. Most commonly, S.
aureus infection manifests as skin and soft tissue infection, but it can also cause pneumonia,
bone and joint infection, bloodstream and cardiac infection, and disseminated disease, among
others (Gorwitz, 2008). The factors that determine whether S. aureus causes localized disease or
more systemic illness are not well-defined but are thought to involve the interplay between the
host’s defense mechanisms and a myriad of bacterial factors. For example, it is known that
individuals with indwelling medical devices, type I diabetes, intravenous drug users,
hemodialysis or surgical patients, and those with the acquired immunodeficiency syndrome are
at higher risk for staphylococcal infection (Lowy, 1998). On the other hand, S. aureus itself can
produce different virulence factors and can have different antibiotic resistance patterns, resulting
in various isolates that may be associated with different clinical disease states (David & Daum,
2010). Most prominent among these various isolates is methicillin-resistant S. aureus (MRSA),
as opposed to methicillin-sensitive S. aureus (MSSA). MRSA is simply a type of S. aureus that
is resistant to many of the antibiotics that could be used to treat MSSA. It was first described in
1961 as a pathogen linked to hospital outbreaks of infection, and over the next 20-30 years, it
became a well-recognized, commonly isolated healthcare-associated bacterium. The first report
of MRSA outside of the healthcare setting occurred in 1982. These first community-associated
cases were isolated only from patients who were IV drug users, but subsequently, MRSA has
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become a prevalent problem in the community at large (David & Daum, 2010; Lowell & Daum,
2008).
Over the past several decades, the increased prevalence of MRSA in the community has
led to more healthcare encounters for illnesses consistent with S. aureus infection. In Emergency
Departments across the country, it was reported that the number of visits for skin and soft tissue
infections (many of which are commonly caused by S. aureus) almost tripled between 1993 and
2005 (Pallin et al., 2008). This report was based upon data from the National Hospital
Ambulatory Medical Care Survey (NHAMCS), which is a national survey of hospital emergency
and outpatient departments that collects administrative data and applies weights based on the
sampling method in order to allow for national generalizability (Centers for Disease Control and
Prevention, 2009). This administrative database does not include any true microbiologic
information, so the bacterial cause of the skin and soft tissue infections could not be verified as
S. aureus. However, with the increase in skin and soft tissue infections being disproportionate to
the overall increase in ED visits during the study (increased from 1.35% of 89 million visits in
1993 to 2.98% of 114 million visits in 2005), this denotes a likely true increase in the rate of skin
and soft tissue infections and a probable increase in the rate of S. aureus infections (Pallin et al.,
2008).
For patients requiring hospitalization related to S. aureus, the National Hospital
Discharge Survey (NHDS) was used to assess the number of hospitalizations in 1999-2000 with
S. aureus discharge codes, and then US Census data was combined with this to estimate the
prevalence of S. aureus hospitalizations nationwide (Kuehnert et al., 2005). While this study
was based upon administrative data, the process of combining national hospital discharge data
specific to S. aureus with US Census data provided a framework for estimating the burden of S.
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aureus hospitalizations across the country. Therefore, this same process was used by later
researchers to observe further trends in the rates of S. aureus hospitalizations. In 2007, Klein,
Smith, and Laxminarayan (2007) reported that the prevalence of S. aureus attributable
hospitalizations increased by 62%, from 294,570 to 477,927 hospitalizations from 1999 to 2005.
Because discharge data did not include reliable differentiation between MRSA and MSSA until
new codes were introduced in 2008, these studies could not directly assess the proportion of
MRSA present. To get around this difficulty, the prevalence of MRSA hospitalization was
estimated from the numbers of resistant isolates in a national lab surveillance network and then
extrapolated to the numbers in the discharge databases. By this process, the prevalence of
MRSA hospitalizations increased by 119% between 1999 and 2005, from 127,036
hospitalizations to 278,203 hospitalizations (Klein, Smith, & Laxminarayan, 2007).
These national studies described amounts of S. aureus disease based upon estimates from
administrative databases, but they also substantiated several smaller studies based upon
laboratory defined S. aureus disease. In 2001 – 2002, Fridkin et al. (2005) performed
prospective laboratory-based surveillance of culture-proven MRSA disease from clinical labs in
Baltimore, MD, Atlanta, GE, and Minnesota, with a focus upon community-associated
infections. The clinical data submitted with the laboratory samples, such as age, sex, and body
site of sample collection, allowed the authors to define some of the basic clinical and
demographic characteristics of patients with MRSA infection. Only seventeen percent of the
12,553 MRSA lab cultures in their study were deemed to represent community-associated
infections and received further analysis (2107 positive cultures). Of these, they found that the
annual incidence rate for community-associated MRSA infection was highest among children <2
years old. Also, 77% of these community-associated infections manifested as skin and soft
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tissue infections, and only 6% occurred as invasive infections including bloodstream infection,
osteomyelitis, or septic arthritis (Fridkin et al., 2005). Then, in 2004 – 2005, Klevens et al.
(2007) used the Centers for Disease Control’s Active Bacterial Core (ABC) surveillance program
to monitor invasive MRSA disease, defined as isolation of MRSA from a normally sterile body
site. The ABC program is a laboratory-based system that, in 2005, included 9 US geographic
areas and represented about 5.6% of the total US population (now includes 10 areas representing
13.6% of the population) (Centers for Disease Control and Prevention, 2011; U.S. Census
Bureau, 2011). In this study, national MRSA incidence rates were calculated by multiplying
site-specific rates with overall U.S. Census data. In contrast to Fridkin’s study, the incidence of
invasive MRSA disease was highest among people >65 years old. Also, by comparing two of
the sites used in Fridkin’s study (Atlanta, GA, and Baltimore, MD), Klevens showed large
increases in the laboratory-proven incidence rates of invasive MRSA disease between 2000 and
2005 (Atlanta: 19.3  33.0 per 100,000; Baltimore: 40.4  116.7 per 100,000) (Klevens et al.,
2007).
While some subsets of pediatric patients were included in the national epidemiologic
studies of S. aureus, relatively few studies have focused specifically upon pediatric populations
for this disease. Kaplan et al. (2005) performed a prospective laboratory-based, single-center
surveillance study in 2001-2004 that looked only at community-associated infections, excluding
all patients with chronic medical conditions, indwelling vascular access lines, or hospitalizations
within the preceding year. During the three year study period, they did see an annual increase in
the overall number of S. aureus isolates for this population (771 in the first year compared to
1562 in the third year), with a greater overall increase in MRSA (2.2-fold) compared to MSSA
(1.7-fold). The vast majority of both MRSA and MSSA infections were manifest as skin and
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soft tissue infections (95.6% and 91.8%, respectively) (Kaplan et al., 2005). Gerber, Coffin,
Smathers, and Zaoutis (2009) used a national administrative database, the Pediatric Health
Information System, to assess the incidence and characteristics of S. aureus infections requiring
hospitalization at any one of thirty-three different free-standing U.S. children’s hospitals between
2002 and 2007. All of this data was based upon discharge diagnostic codes, and the distinction
between MRSA and MSSA was based solely upon the presence or absence of a code denoting
infection with resistant organisms. Despite this limitation, during the 6 years of the study, there
was an overall increase in the incidence of S. aureus infection (20.8  35.8 cases per 1000
admissions) as well as in increase in the incidence of MRSA infection (6.7  21.2 cases per
1000 admissions). Though not all patients had the site of infection noted, of those who did, 61%
involved the skin and soft tissues. As noted by the researchers, one of the major limitations of
this study was that “the accuracy of ICD-9 codes for diagnosis of either S. aureus or MRSA
infection has not been validated for this large population” (Gerber, Coffin, Smathers, & Zaoutis,
2009).
With regard to more invasive disease, the first reports of fatal MRSA infection in
pediatric patients came from the Minnesota-North Dakota area in 1999. The report described
four patients between the ages of 12 months and 13 years who were from various socioeconomic
and geographic backgrounds and who all succumbed to invasive MRSA infection ("Four
pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus Minnesota and North Dakota, 1997-1999," 1999). Other reports of invasive MRSA disease in
pediatric patients were described in the Houston, TX and Chicago, IL areas in the early 2000’s
(Gonzalez et al., 2005; Mongkolrattanothai, Boyle, Kahana, & Daum, 2003). Gonzalez et al.
(2005) in TX noted an increase in pediatric patients presenting with severe MRSA sepsis from 1
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case in 1999-2002 to 14 cases in 2002-2004. Mongkolrattanothai, Boyle, Kahana, and Daum
(2003) tested several invasive strains of MRSA isolated from pediatric patients in IL and found
the strains to be genetically similar to MSSA strains that were already prominent in the
community. This suggested that the community MRSA isolates may have evolved within the
previous background of MSSA disease already present (Mongkolrattanothai et al., 2003).
Looking specifically at bloodstream infections due to MRSA, Carrillo-Marquez, Hulten, Mason,
and Kaplan (2010) retrospectively analyzed laboratory-based, single-center pediatric data
surveilling for central vascular catheter associated S. aureus infections in 2001-2007. They
found 124 episodes of S. aureus isolates causing bacteremia in 112 children. Of these, MRSA
isolates comprised only 25.9% of all of the S. aureus infections (Carrillo-Marquez, Hulten,
Mason, & Kaplan, 2010).
Given this relative lack of national epidemiologic information regarding pediatric S.
aureus disease along with the overall increased incidence of MRSA infection in general, further
studies assessing pediatric S. aureus epidemiology are warranted. However, since laboratory and
clinical-based epidemiologic studies can be very complex and only representative of the local
population, the use of larger administrative databases including discharge diagnosis data could
provide a simpler assessment of the disease burden. This method has been used in several of the
previously mentioned studies, but the technique requires validation in pediatric S. aureus disease.
Similar validity tests have already been examined for other types of pediatric infections. In
2000-2001, Hsu et al. (2005) tested the validity of rotavirus discharge codes compared to
laboratory testing in an active surveillance program at one pediatric institution. This study
showed that the rotavirus discharge code only had a sensitivity of about 47%, thereby missing
over half of all laboratory-proven cases (Hsu et al., 2005). In 2001-2004, Keren et al. (2006)
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tested the validity of influenza discharge codes compared to all hospitalized patients with
laboratory confirmed influenza. Here, the influenza discharge code had a sensitivity of about
65%, missing 35% of the laboratory-proven cases (Keren et al., 2006). Clearly, in these other
infectious processes, the administrative data alone seems to be underrepresentative of the total
disease burden, to variable extents.
For S. aureus, and specifically MRSA, no studies have assessed the validity of discharge
coding to represent clinical disease in pediatric patients. For adult patients, this has been
evaluated somewhat, particularly because certain states have passed legislation mandating the
use of discharge diagnosis codes for reporting healthcare-associated infections including MRSA
(Schaefer et al., 2010). At a single adult medical center during 2005-2007, Schaefer et al. (2010)
correlated MRSA specific discharge diagnostic codes with confirmed MRSA cases. In this
study, discharge codes only had a sensitivity of about 59% compared to cases confirmed by lab
results and chart review, but the codes had a positive predictive value of 93%. Unfortunately,
this study was completed prior to the introduction of the new MRSA-specific discharge codes in
2008, so the applicability of the results to the new codes is unknown (Schaefer et al., 2010).
Given the ongoing importance of MRSA infection among pediatric populations and the
need for better epidemiology of the disease in this age group, more studies will likely make use
of administrative datasets in order to better understand the burden of disease. Therefore, the
purpose of this project is to assess the sensitivity and positive predictive value of discharge
diagnosis codes for MRSA bloodstream infections, so as to better understand the limitations of
using administrative data to track this disease.
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Methods
Sampling
The population of study in this project is all patients less than 20 years old hospitalized at
Cincinnati Children’s Hospital Medical Center (CCHMC) from October 2008 through December
2010 with MRSA bloodstream infections. Bloodstream infections were chosen because this type
of infection was felt to be the “most clean.” In other words, from a clinical standpoint, blood
cultures that grow S. aureus are almost always treated as true infections. This may not be the
case for other cultures that grow S. aureus, in which the positive result may be more likely
interpreted as colonization or contamination. Therefore, it was thought that bloodstream
infections would likely have the strongest correlation between administrative and lab data,
compared to other types of MRSA infection.
The sampling frames for this population include the database generated by CCHMC
Infection Control Program (a.k.a. lab database) and the database generated by CCHMC Finance
and Health Information Management Department (a.k.a. discharge database). The lab database
contains all positive blood cultures from the Clinical Laboratory, and the discharge database
contains all discharge codes for any given hospitalization. From the lab database, subjects were
selected if they had a positive blood culture for MRSA; from the discharge database, subjects
were selected if they had a discharge code indicating MRSA bloodstream infection (038.12 for
MRSA sepsis or 041.12 for MRSA infection with either 790.7 for bacteremia or 771.81 for
newborn sepsis or 771.83 for newborn bacteremia). From these frames, no direct sampling
method was used, but rather all hospitalizations which met the selection criteria were included.
Once the hospitalization was identified by either positive blood culture or positive discharge
code, the corresponding medical record was reviewed. Through chart review, if the medical

CORRELATION OF ICD-9 CODES WITH MRSA BLOODSTREAM INFECTION

15

providers prescribed treatment (most commonly the use of antimicrobials against MRSA) then
the hospitalization was counted as having true MRSA infection. Also through chart review,
additional clinical information was obtained, including the presence or absence of underlying
chronic medical disease and the clinical manifestations of the bloodstream infection. Categories
were established for both underlying disease and clinical manifestations associated with the
bloodstream infection. The estimated incidence of MRSA bloodstream infection at CCHMC is
approximately 25 hospitalizations per year, resulting in 50 – 75 subjects for this study.
Measurement
The primary constructs utilized in this project are MRSA bloodstream infection and
MRSA discharge diagnostic coding. To measure MRSA bloodstream infection, the construct
was operationalized by selecting all positive blood cultures for MRSA from the lab database,
determining the associated hospitalization, and then reviewing the corresponding medical record
to assure true MRSA disease. In this way, the combination of positive blood culture result
together with clinical information abstracted from the chart review served as the “gold standard”
for defining MRSA bloodstream infection. To measure MRSA discharge diagnostic coding, this
construct was operationalized by selecting all medical records from the discharge database that
contained certain ICD-9 codes. In order to determine which ICD-9 codes to use, the goal was to
include only those codes that would represent MRSA bloodstream infection, excluding other
MRSA infections that did not involve the bloodstream. Per the Centers for Medicare &
Medicaid Services, there are only three codes which indicate MRSA infection in ICD-9. Those
are 038.12 for MRSA sepsis, 041.12 for MRSA infection elsewhere, and 482.12 for MRSA
pneumonia. Prior to October 2008, MRSA infection had to be coded by using a S. aureus code
in combination with an antibiotic resistance code, but this need has now been obviated by the
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introduction of the MRSA-specific codes (Centers for Medicare & Medicaid Services, 2011).
For this study, in order to capture all potential cases of MRSA bloodstream infection, 038.12 was
selected along with the combinations of 041.12 with 790.7 for bacteremia or 041.12 with 771.81
for newborn sepsis or 041.12 with 771.83 for newborn bacteremia. The only other MRSA
specific code, 482.42 for MRSA pneumonia, would still require an additional MRSA sepsis or
MRSA infection with bacteremia code if the patient’s pneumonia was accompanied by
bloodstream involvement (personal communication with CCHMC Health Information
Management coding specialist, July 13, 2011). Thus, the aforementioned codes should capture
all instances of MRSA bloodstream infection.
The secondary constructs for this project include chronic underlying disease and clinical
manifestations of MRSA bloodstream infection. To measure these, the constructs were
operationalized by denoting specific categories for each on medical record review. Chronic
underlying disease was categorized as the presence or absence of any of the following
conditions: cancer, chronic otitis media, chronic skin disease, diabetes mellitus, genetic /
metabolic disorder, immune deficiency, lung disease, neurologic disease, prematurity ≤ 36 weeks
gestation, prior transplant, renal disease, liver disease, cardiac disease, hematologic disease, GI
disease, or “other chronic illness.” Based upon medical record review, each hospitalization was
categorized as either having no chronic medical disease or having chronic disease in one of these
categories. Similarly, the clinical manifestations of MRSA bloodstream infection were divided
into the following categories: disseminated disease, primary bacteremia, osteomyelitis, joint /
bursa infection, pulmonary infection, ear-nose-throat infection, intraabdominal infection, deep
tissue infection, central nervous system infection, urinary tract infection, or skin / soft tissue
infection. Bloodstream infection may occur in the setting of any of these manifestations, and
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each hospitalization was categorized into one of these groups based upon medical record review.
For purposes of this project, the groups were established to be mutually exclusive. So, a
hospitalization was only assigned to one clinical manifestation group, based upon the primary
presentation.
Data Collection and Analysis
The initial list of positive MRSA blood cultures was generated from the lab database and
then reviewed to find all associated hospitalizations. All medical records for these
hospitalizations were then obtained and reviewed. Clinical information from the medical record,
including verification of MRSA infection, presence or absence of chronic disease, and the
associated clinical manifestation, was recorded on a case report form and entered into an
electronic management database. If on chart review, the positive blood culture was found not to
indicate true infection (e.g.: colonization or contamination), the hospitalization was not included
in further analysis.
The list of positive MRSA bloodstream infection discharge codes was generated from the
discharge database and then reviewed for overlap with the lab database. For any hospitalizations
not previously identified, medical records were obtained and reviewed. In this way, all
hospitalizations could be categorized as either MRSA bloodstream infection with MRSA
bloodstream discharge code, or MRSA bloodstream infection without MRSA bloodstream
discharge code, or MRSA bloodstream discharge code without MRSA bloodstream infection.
Subsequently, two-by-two tables could be constructed (Table 1) in order to determine the
sensitivity and the positive predictive value of the MRSA ICD-9 codes.
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Table 1. Sample two-by-two table

MRSA

code for

Discharge

ICD-9

Blood culture for MRSA
+

-

+

a

b

-

c

d

Once the two-by-two tables are created, the sensitivity of the ICD-9 code is calculated as
a/(a+c), and the positive predictive value as a/(a+b). 95% confidence intervals (95% CI) can also
be calculated for each of these ratios based upon the sample sizes, using the “plus-4 method” for
sample sizes ≥10 or the Fischer exact test for sample sizes <10 (Gerstman, 2008b).
Unfortunately, because there is no way to determine the value of box d, this data will not allow
for determination of specificity or negative predictive value. In addition to determining the
overall sensitivity and positive predictive value for all MRSA bloodstream infections, these
measures are also calculated for each year, for presence or absence of chronic disease, and for
each different clinical manifestation. Categorical differences between these groups are then
assessed using chi-square measurements, with results considered significant at an α level of 0.05
(Gerstman, 2008a).
Aside from the quantitative outcomes noted above, a qualitative assessment will be made
to understand the reasons why some hospitalizations were not congruent in both the lab and
discharge databases. This will be done by reviewing the data to see if themes arise that may
account for why a hospitalization with MRSA bloodstream infection did not have the appropriate
discharge code or why a hospitalization with MRSA bloodstream discharge codes did not have a
positive MRSA blood culture in the lab. If consistent themes become evident for these
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scenarios, then these may serve as potential starting points for improving the sensitivity and
positive predictive value of the discharge codes over time.
Research Ethics
This project was approved by the CCHMC Institutional Review Board (see Appendix) as
part of the larger approved study, “Determining the Burden of Staphylococcus aureus Disease in
the Cincinnati Metropolitan Area.” The IRB approval number is 2010-1450 and expires on
4/26/2013.
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Results
The total number of hospitalizations at CCHMC identified through the lab database for
positive MRSA blood culture during October 2008 – December 2010 was 65; the total number of
hospitalizations identified through the discharge database for positive discharge code indicating
MRSA bloodstream infection was 58. Thirty-six were concordant and 51 were discordant,
resulting in a total of 87 hospitalizations for chart review and analysis. Among the 65
hospitalizations identified from the lab database, all positive MRSA blood cultures were deemed
true infections based upon chart review because the medical providers prescribed treatment in
every case.
Two-by-two tables were constructed for total and yearly lab and discharge data (Figure
1). The lab data are denoted as positive or negative based upon whether or not there was a
positive blood culture for MRSA. The discharge data are denoted as positive or negative based
upon whether or not one of the four possible ICD-9 discharge codes or code combinations for
MRSA bloodstream infection was present. The overall sensitivity was 55.4%, with 95% CI =
43.3% - 66.8%, and the overall positive predictive value was 62.1%, with 95% CI = 49.2% 73.4%. Of note, there were far fewer cases in 2008 compared to 2009 or 2010 because of the
limited number of months in 2008 (only October – December due to the timing of introduction of
MRSA-specific codes). Of the 36 hospitalizations appropriately coded for MRSA bloodstream
infection, only one-third (12 cases) were coded using the single MRSA sepsis code of 038.12.
The other two-thirds used code combinations, including an MRSA infection code, 041.12,
together with a code indicating bloodstream infection, either 790.7 or 771.81 or 771.83.
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Chi-square analysis for trend was performed in order to assess how the yearly
sensitivities and positive predictive values changed over time. While the positive predictive
value did increase each year, from 44.4% in 2008 to 70.4% in 2010, neither the positive
predictive value nor the sensitivity demonstrated a statistically significant trend over the study
period (Figure 2).

Figure 2. Chi-square trend analyses for yearly (a) sensitivities and (b) positive predictive values
For further analysis of the calculated sensitivity, hospitalizations were subdivided among
those involving patients with or without chronic medical conditions, and among those involving
each various clinical manifestation of MRSA bloodstream infection. The sensitivity of the ICD9 codes in each group is shown in Table 2, along with the number of subjects and the 95%
confidence intervals. Cases of Primary Bacteremia were also further divided out depending upon
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the presence of absence of a central venous catheter (CVC). As can be seen in Table 2, central
venous catheters were associated with 73.7% (14 out of 19) of the total cases of MRSA primary
bacteremia.
Table 2. Sensitivity, by chronic disease and by primary clinical manifestation of MRSA
bloodstream infection
Condition

Number

Sensitivity

95% CI

YES

34

61.8%

45.0, 76.1

NO

31

48.4%

32.0, 65.1

19

78.9%

56.0, 91.9

CVC-associated

14

78.6%

51.5, 92.9

Not CVC-associated

5

80.0%

28.4, 99.5

Osteomyelitis

17

35.3%

17.3, 58.9

Disseminated

10

60.0%

31.2, 83.1

Skin / Soft Tissue

6

33.3%

4.3, 77.7

Joint / Bursa

5

40.0%

5.3, 85.3

Pulmonary

5

60.0%

14.7, 94.7

ENT

1

100.0%

2.5, 100.0

Deep Tissue

1

100.0%

2.5, 100.0

CNS

1

0.0%

0.0, 97.5

Intraabdominal

0

N/A

N/A

Urinary Tract

0

N/A

N/A

Chronic Disease Present

Clinical Manifestation
Primary Bacteremia

Groups with the largest sample sizes were then selected for further comparison.
Specifically, chi-square comparisons were made between those with chronic disease vs. those
without chronic disease and also between those with primary bacteremia vs. those with
osteomyelitis (Figure 3). Because of the small number of hospitalizations in all other groups, no
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other between-group comparisons were made. There was not a statistically significant difference
between the sensitivity of the group with chronic disease vs. the group without chronic disease.
However, there was a significant difference, with p <0.01, between the sensitivity of the primary
bacteremia group vs. the osteomyelitis group.

Figure 3. Chi-square analyses of sensitivity between groups, (a) chronic disease vs. no chronic
disease and (b) primary bacteremia vs. osteomyelitis
Next, the discordant hospitalizations (those in either the lab database or the discharge
database, but not both) were qualitatively assessed to determine any underlying themes for why
they were found in one or the other, but not both databases. For the hospitalizations from only
the lab database, there were several reasons why they did not meet ICD-9 discharge coding
criteria for MRSA bloodstream infection (Table 3). Most common among these was that an
MRSA infection code was present, but not a code denoting any bloodstream involvement of the
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infection. Of note, five hospitalizations with MRSA bloodstream infection were coded as having
MSSA bloodstream infection instead.
Table 3. Reasons for discordance between discharge and lab databases in patients with a
positive MRSA blood culture
Reason (total number = 29)

Number

Percent

MRSA infection code present, but no bloodstream code

16

55.2%

MSSA sepsis code or MSSA infection code with bloodstream code

5

17.2%

Neither MRSA infection code nor bloodstream code present

5

17.2%

Bloodstream code present, but no MRSA infection code

3

10.4%

present, but nothing denoting MRSA infection

For the hospitalizations from only the discharge database, there were also several reasons
why they did not have any lab blood cultures positive for MRSA (Table 4). Most common
among these was that the patient had a localized MRSA infection without bloodstream
involvement, but a bloodstream infection code was generated for another reason, such as a blood
culture with a different organism. Of note, eight hospitalizations involving bloodstream
infections due to MSSA received hospital discharge codes indicating MRSA bloodstream
infection instead.
Table 4. Reasons for discordance between discharge and lab databases in patients without a
positive MRSA blood culture
Reason (total number = 22)

Number

Percent

Localized MRSA infection without evidence of bloodstream involvement 10

45.4%

MSSA bloodstream infection, rather than MRSA

8

36.4%

MRSA colonization only (no treatment provided)

2

9.1%

Prior hospitalization with MRSA bloodstream infection, but no new

2

9.1%

infection during the current admission
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Discussion
The results of this study support the research hypothesis that ICD-9 hospital discharge
codes specific to MRSA bloodstream infection would only moderately correlate with laboratoryconfirmed MRSA bloodstream infection. In fact, the overall sensitivity and positive predictive
value of the codes was quite low, at 55.4% and 62.1%, respectively. This finding implies that if
administrative data, such as the ICD-9 codes used in this study, were employed to monitor
MRSA bloodstream infection in pediatric hospitalizations, almost 45% of the total actual MRSA
bloodstream infections would be missed. Further, of the hospitalizations identified by the use of
these codes, almost 40% of them would not even involve an MRSA bloodstream infection at all.
Clearly, these findings demonstrate the inherent difficulties in using administrative data to define
particular clinical scenarios.
Over the time period involved in this study, both the sensitivity and positive predictive
value increased, but not with a statistically significant trend. The increase may represent some
improved familiarity with the new diagnosis codes over time, but the fact that there was no
significant trend shows the relatively static nature of the underlying reasons for inaccuracy. For
example, a major difficulty with both the sensitivity and positive predictive value measurements
was that two codes, both an etiology and a manifestation code, often had to be present in order to
meet the ICD-9 coding criteria for this study. While requiring both codes certainly affected the
study outcomes (65% of the discordant hospitalizations in Table 3 had one or the other but not
both), there is no other way to indicate the presence of MRSA bloodstream infection as opposed
to some other type of MRSA infection. The MRSA sepsis code, 038.12, can be used as a single
code to indicate MRSA bloodstream infection, but even among the appropriately coded
hospitalizations, only one-third utilized this code. Presumably, the remaining hospitalizations
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could not use this code because the patients had bacteremia (bloodstream infection) rather than
true sepsis (bloodstream infection with more severe clinical findings such as low blood pressure).
Unfortunately, this study was not designed to tease out the clinical differences between
bacteremia and sepsis, and so the sensitivity of the single code for sepsis vs. the combined codes
for bacteremia could not be assessed. Regarding the positive predictive value, the combination
of codes was also problematic in that many hospitalizations coded for MRSA bloodstream
infection really only had localized MRSA disease without a bloodstream component (45% of the
discordant hospitalizations in Table 4). This finding was due to the presence of a localized
MRSA infection together with a completely separate bloodstream infection due to a different
organism, and coding for both conditions. Because there is no mechanism to link etiology and
manifestation codes, these hospitalizations were misidentified by the administrative data as
having MRSA bloodstream infection when they really did not.
Of note, the current national discharge coding system, ICD-9, will be replaced on
October 1, 2014 with a new system, ICD-10. Per the Center for Medicare & Medicaid Services
website, the new ICD-10 data will include thousands more codes, thus allowing the diagnostic
codes to more accurately reflect various different clinical scenarios. Hopefully, this new coding
system would then allow for better quality assessments by “facilitat[ing] evaluation of medical
processes and outcomes” (Centers for Medicare & Medicaid Services, 2010). Unfortunately
though, in order to evaluate the medical processes and outcomes surrounding MRSA
bloodstream infection, identification of this clinical entity may still be problematic. Though
there will be many more codes within the ICD-10 system, combinations of codes will still be
required in order to fully describe the etiology and manifestation of infections, including MRSA
bloodstream infections. Like the current ICD-9, the only intrinsically combined MRSA codes
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will be those for sepsis and pneumonia (Centers for Medicare & Medicaid Services, 2012).
Therefore, it is concerning that the same difficulties with sensitivity and positive predictive value
that were seen in this study will persist despite the adoption of ICD-10.
Interestingly, the sensitivity of the discharge codes seemed to vary with the clinical
manifestation of bloodstream infection. In this study, the sensitivity of the codes for
hospitalizations involving MRSA primary bacteremia was 78.9%, while the sensitivity of the
codes for osteomyelitis-associated MRSA bloodstream infection was only 35.3%. This
difference was statistically significant, with a p-value < 0.01. While the exact reasons are not
clearly defined, it may be postulated that the relative clinical importance of the bloodstream
component of infection may be different for these different clinical situations. For example, if a
patient is hospitalized because of primary bacteremia, then treating the bloodstream infection is
the main purpose of the hospitalization. On the other hand, if a patient is hospitalized because of
osteomyelitis and the bacteremia is noted incidentally or in support of the osteomyelitis, then
treating the bone infection remains the main purpose of the hospitalization. Therefore, the
physician may be more likely to appropriately document the MRSA bloodstream infection in the
first scenario compared to the second because it is not as clinically relevant. Because discharge
codes are generated by hospital coders based directly upon physician documentation, a
difference in physician documentation would certainly lead to differences in coding and
subsequent measurements of code sensitivity. Unfortunately, in this study, the groups with other
manifestations of MRSA bloodstream infection were too small to allow for reasonable analysis
of other between-group differences.
When comparing the groups with chronic disease vs. those without chronic disease, this
study was not able to detect a statistically significant difference in sensitivity between them.
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Before starting this project, the author presumed that the sensitivity of the codes would be higher
among patients without chronic disease because of the inherent surprise that is usually associated
with a diagnosis of serious invasive infection in an otherwise healthy individual. On the contrary
though, the point estimate for sensitivity among patients without chronic disease was actually
lower than that for patients with chronic disease. Because of the limited number of subjects, this
difference did not reach statistical significance. More hospitalizations would have to be
reviewed in order to see if there really is a difference and if so, which group has the higher
sensitivity. Further, any difference in sensitivity between these two groups could also be due to
the underlying differences in sensitivity that were seen with the varied clinical manifestations, as
discussed previously.
This study exemplifies many issues encountered in the core areas of public health,
including epidemiology, biostatistics, environmental health, health economics, health systems,
and global health. In terms of epidemiology, the burden of MRSA disease certainly seems to
have increased over the past 10 years, and better methods should be employed to track this
illness, as noted in the introduction. Administrative data are an attractive source for monitoring,
but significant differences exist between clinical data and their reflection in administrative data.
These differences were demonstrated clearly in this project by the low sensitivity and positive
predictive values observed for discharge coding of MRSA bloodstream infection. In terms of
biostatistics, the sensitivity and positive predictive value measured in this study are commonly
used tools for various diagnostic tests in medicine. However, the closeness of these
measurements to the truth is based largely upon the sample size from which they are calculated.
As a result, this study provided samples large enough to generate reasonable sensitivities and
positive predictive values, but not large enough to allow for many comparisons between groups.
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Further studies are needed in order to more precisely measure the sensitivity and positive
predictive value in specific populations, and therefore more accurately generalize these results to
those groups. In terms of environmental health, MRSA has become a ubiquitous pathogen, with
large portions of the population simply colonized with this bacteria (Lowell & Daum, 2008).
However, MRSA is still often considered a nosocomial pathogen in the hospital environment.
Further, people who have more healthcare exposures overall are more likely to develop
nosocomial infections (Lowy, 1998). In this project, such a predisposition to MRSA
bloodstream infection was seen in that over three-fourths of the cases of MRSA primary
bacteremia were associated with an indwelling central venous catheter. Unfortunately, because
the total number of hospitalizations involving central venous catheters during the study period is
unknown, the difference between these two groups cannot really be assessed statistically.
However, the predominance of central vascular catheter associated infections seen here still
highlights the vital importance of environmental measures affecting care and maintenance of
medical devices to prevent infection. In terms of health economics, many researchers have
attempted to examine the cost difference between infections with MRSA vs. MSSA. While it
may seem that infection with MRSA is more expensive to the total healthcare system because of
the cost of more potent antibiotics, this presumption has not always been born out in the
literature. In fact, depending upon the statistical method used to compare the two types of
infection, some differences have been seen in overall costs and length of hospitalization while
others have not (Ben-David, Novikov, & Mermel, 2009; Cosgrove et al., 2005). This project did
not focus specifically on the economic impact of MRSA bloodstream infection, but further
analysis could be performed using this data in conjunction with data on MSSA bacteremia during
the same time period to determine whether or not there were significant differences in lengths of
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hospitalization and overall costs. Determining the proportion of the expenses specifically due to
the MRSA or MSSA infection though, as opposed to other medical issues that arise during the
hospitalization, may be much more difficult. In terms of health care systems, this project
examined a fundamental part of the link between health care providers and health care payers,
namely diagnostic codes. These diagnostic codes are fundamental because they provide a
dominant portion of the determination of reimbursement for healthcare services. As medical
care in this country still largely functions in a fee-for-service modality, the fees generated should
be proportional to the services provided which, for hospitalizations, are often estimated based
upon the discharge diagnoses present. So, in theory, the more accurately the discharge diagnoses
reflect the underlying clinical situations, the more relevant the fees charged to the payers and the
more appropriate the reimbursements paid to the hospital and providers. Lastly, in terms of
global health, MRSA infection is a problem in patients worldwide, though the extent of the
disease burden seems to vary geographically. Per 2008 monitoring data from the European
Union, the percentage of blood isolates of S. aureus that were methicillin-resistant varied from
<5% in some countries to >50% in others (Kock et al., 2010). Data for MRSA infection in
developing countries is much sparser. Difficulties that have been cited for developing countries
include the lack of diagnostic microbiologic laboratories necessary to identify MRSA. For this
reason, “almost nothing is known about the emergence and transmission of MRSA in resourcepoor regions of the world” (Nickerson, West, Day, & Peacock, 2009). However, some emerging
data from China and India suggests that MRSA may account for a significant portion of S.
aureus disease in these countries. Additionally, the ready availability of over-the-counter
antibiotics in developing countries raises concern for the further emergence of community-
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associated MRSA (Nickerson et al., 2009). Therefore, better surveillance methods for MRSA
infection are needed, not only in the United States, but also globally as well.
This project has several important limitations. First, the fact that all of the data was
collected from a single center limits the generalizability of the results. The concept of proximal
similarity indicates that results from a study can be generalized to other populations depending
upon how similar or dissimilar the two groups are. So, for this project, populations that would be
more similar include those hospitalizations in a similar geographic area (as the epidemiology of
MRSA infections may vary from one part of the country to another), those involving tertiary
free-standing children’s hospitals, and those with a similar process of coders assigning discharge
codes based upon physician documentation in the medical record (rather than physicians
assigning the codes themselves). Additionally, because the incidence of MRSA infection seems
to be evolving over time, proximal similarity would also indicate applicability of the data to the
present and near future, but not necessarily to the more distant future. However, even if all of
these criteria are met, there still may be some amount of inter-institutional variability in the
coding sensitivity and positive predictive value. Therefore, in order to apply the outcomes of
this study to national administrative datasets, this project would likely need to be repeated at
other institutions that provide inpatient pediatric care. Second, the inclusion dates of the
discharge database and the lab database were not exactly the same. Initially, hospitalizations
were identified from the lab database if the admission date of the hospitalization occurred within
30 days of the date of the positive culture. Because this method could omit some prolonged
hospitalizations in which the positive culture did not occur within the first 30 days of admission,
the database was re-queried without this time limit. When this was completed, no additional
hospitalizations were identified. For the discharge database, the initial query was for
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hospitalizations that had both admission and discharge dates within the timeframe in question.
However, this method could have omitted hospitalizations in which the patient was admitted
before October 1, 2008 or discharged after December 31, 2010. So, the database was rerun with
a broader time window, and only 1 additional hospitalization was identified. Therefore, the date
ranges used for querying the two databases would need to be considered if repeating this project
at another institution in order to make sure no hospitalizations were missed. Third, there is a
possibility for confounding bias since some patients could be involved in more than one
hospitalization. In fact, in this project, there were two patients who were admitted multiple times
with different episodes of MRSA bloodstream infection. However, both of these patients had
hospitalizations separated over considerable time periods, and therefore the patients likely had
distinct episodes of MRSA bloodstream infection. Thus, two out of the total 65 hospitalizations
identified from lab data did not represent the first time the patient had MRSA bacteremia. These
hospitalizations did not likely affect the measured sensitivities or positive predictive values
though, since the coding process should be independent of the patient’s history of prior similar
infections.
In summary, this project showed the important finding of low sensitivity and positive
predictive value of ICD-9 discharge codes for pediatric MRSA bloodstream infections. By
qualitative review, a substantial reason for these low measures is the need for multiple codes to
document etiology and manifestation of infection, and this may not be specifically addressed by
the new ICD-10 coding system. In order to generalize these results and apply them to national
administrative datasets, further validation studies in other pediatric institutions will be required.
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Appendix B: Tier 1 Core Public Health Competencies Used in CE
Domain #1: Analytic/Assessment
Identify the health status of populations and their related determinants of health and illness (e.g., factors
contributing to health promotion and disease prevention, the quality, availability and use of health services)
Describe the characteristics of a population-based health problem (e.g., equity, social determinants,
environment)
Use variables that measure public health conditions
Use methods and instruments for collecting valid and reliable quantitative and qualitative data
Identify sources of public health data and information
Recognize the integrity and comparability of data
Identify gaps in data sources
Adhere to ethical principles in the collection, maintenance, use, and dissemination of data and information
Describe the public health applications of quantitative and qualitative data
Collect quantitative and qualitative community data (e.g., risks and benefits to the community, health and
resource needs)
Use information technology to collect, store, and retrieve data
Describe how data are used to address scientific, political, ethical, and social public health issues

Domain #2: Policy Development and Program Planning
Gather information relevant to specific public health policy issues
Gather information that will inform policy decisions (e.g., health, fiscal, administrative, legal, ethical, social,
political)
Describe the public health laws and regulations governing public health programs
Identify mechanisms to monitor and evaluate programs for their effectiveness and quality
Demonstrate the use of public health informatics practices and procedures (e.g., use of information systems
infrastructure to improve health outcomes)

Domain #3: Communication
Communicate in writing and orally, in person, and through electronic means, with linguistic and cultural
proficiency
Solicit community-based input from individuals and organizations
Convey public health information using a variety of approaches (e.g., social networks, media, blogs)
Participate in the development of demographic, statistical, programmatic and scientific presentations

Domain #4: Cultural Competency
Recognize the role of cultural, social, and behavioral factors in the accessibility, availability, acceptability and
delivery of public health services
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Domain #5: Community Dimensions of Practice
Recognize community linkages and relationships among multiple factors (or determinants) affecting health
(e.g., The Socio-Ecological Model)
Identify stakeholders
Maintain partnerships with key stakeholders
Describe the role of governmental and non-governmental organizations in the delivery of community health
services

Domain #6:Public Health Sciences
Relate public health science skills to the Core Public Health Functions and Ten Essential Services of Public
Health
Identify the basic public health sciences (including, but not limited to biostatistics, epidemiology, environmental
health sciences, health services administration, and social and behavioral health sciences)
Describe the scientific evidence related to a public health issue, concern, or, intervention
Retrieve scientific evidence from a variety of text and electronic sources
Discuss the limitations of research findings (e.g., limitations of data sources, importance of observations and
interrelationships)
Describe the laws, regulations, policies and procedures for the ethical conduct of research (e.g., patient
confidentiality, human subject processes)

Domain #7: Financial Planning and Management
Adhere to the organization’s policies and procedures
Report program performance
Apply basic human relations skills to internal collaborations, motivation of colleagues, and resolution of
conflicts
Demonstrate public health informatics skills to improve program and business operations (e.g., performance
management and improvement)

Domain #8: Leadership and Systems Thinking
Incorporate ethical standards of practice as the basis of all interactions with organizations, communities, and
individuals
Identify internal and external problems that may affect the delivery of Essential Public Health Services
Use individual, team and organizational learning opportunities for personal and professional development
Participate in the measuring, reporting and continuous improvement of organizational performance
Describe the impact of changes in the public health system, and larger social, political, economic environment
on organizational practices
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